PHARMATECA » Search Articles by Keyword

Found: 7 articles

Article	Edition
M.B. Antsiferov CLINICAL CHARACTERISTICS AND PRACTICAL ASPECTS OF THE USE OF NEW BASAL INSULIN GLARGINE 300 U/ ML TOUJEO SOLOSTAR®	№16 / 2016
I.V. Glinkina ORIGIN STUDY (OUTCOME REDUCTION WITH INITIAL GLARGINE INTERVENTION) 2 YEARS LATER: WHAT’S NEW?	№16 / 2014
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2 BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE	№16 / 2013
M.B. Antsiferov 1, E.V. Biryukova 2 , A.V. Zilov 3 Early Use Of Insulin Glargine In Patients With Type 2 Diabetes Mellitus, Pre-diabetes And High Cardiovascular Risk: Results Of Origin Study	№16 / 2012
N. A. Chernikova, M.A. Prudnikova Timely Administration Of Insulin Therapy In Type 2 Diabetes Mellitus	№3 / 2012
Glinkina I.V., Romancova T.I. Results Of Observational Program On Use Of Insulin Glargine (lantus®) In Combination With Oral Hypoglycemic Agents For The Treatment Of Type 2 Diabetes Mellitus In Routine Clinical Practice	№3 / 2011
M.Antsiferov С. 1621 Use Of Long-acting Insulin Analogues In Type 2 Diabetes Mellitus Treatment (according To The Data Of International And Russian Registries)	№3 / 2010